Group 6C: Triple Negative Breast Cancer; Brain Metastasis; Clinical Trials; Novel Targets & Therapies
Thursday, June 15 6:00 pm – 7:30 pm Eastern Time (US/New York)
Mentor: Abigail Johnston, Esq
Abigail is a recovering lawyer, living in Florida with her husband and two boys, and has lived with de novo Stage IV Metastatic Breast Cancer (MBC) since 2017. Advocacy and bringing the patient voice to all levels of health care and research is her passion and Abigail is honored to serve as a mentor with GRASP as well as on the Inaugural Advisory Board. You can find her musings on her blog, www.NoHalfMeasures.blog.
Scientist: Jamie Spangler, Ph.D.
Dr. Jamie Spangler’s research aims to expand the repertoire of protein therapeutics by redesigning naturally occurring proteins and engineering new molecules to overcome the deficiencies of existing drugs. Integrating cutting-edge tools from structural biophysics, biomolecular engineering, and translational immunology, her research focuses on developing innovative platforms for the discovery and design of proteins that recruit novel mechanisms for disease therapy. In particular, Spangler’s group is interested in engineering antibody-based molecules that reshape immune cell behavior for targeted treatment of cancer, infectious diseases, and autoimmune disorders. The overarching goal of her interdisciplinary research program is to establish new insights into protein behavior and the extent to which it can be manipulated for medically relevant applications.